Home Analyst Ratings HC Wainwright & Co. maintains ESSA Pharma at Buy rating with...

HC Wainwright & Co. maintains ESSA Pharma [EPIX] at Buy rating with a $17 price target

HC Wainwright & Co. maintained its ESSA Pharma [EPIX] rating to the equivalent of Buy but changed the price target to $17.0 from $10, in a research note dated 2021-01-11. That figure represents around a 41.43% premium from where the company’s shares closed on Friday. Some new analysts also started their coverage, with Oppenheimer’s analysts assigning the shares to “an Outperform” rating in a research note to investors issued in late October.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is ESSA Pharma Inc. [NASDAQ:EPIX] a Good Buy Right Now?

It should be noted that EPIX technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 100% Buy in the last week and compares with 72% Buy in the past month. Data from ESSA Pharma Inc.’s Trend Spotter indicated that the signals were Weakest. The stock current average is 0.22 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 0.17 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.14 million shares.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

EPIX Price Performance

On Wall Street, ESSA Pharma Inc. [NASDAQ:EPIX] finished Friday’s session down -6.09% at $12.02. The stock went up to $12.90 at the same session while its lowest single day price was $11.6301. In the last five days, it saw a rise of about 0.75%, ESSA Pharma Inc. shares gained by almost 0.75% since the beginning of the year. However, the share price has dropped to as low as -9.08% below its one year high. On 01/07/21, the company shares recorded $13.22, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $11.27. The company’s shares have inclined by 109.04% in the past year. The 50-day SMA achieved is $7.75 while the 200-day SMA is $6.30. Volume dropped to 0.57 million from 0.64 million in the previous session.

EPIX Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 11.47 level, and in case of violation of this particular level, it will cause more drop to 10.91 level. On the upper level, 13.45 is still the key resistance. The stock may increase to the subsequent resistance at 12.74. The Relative Strength Index (RSI) pinned on the 14-day chart is 72.88, implying a overbought technical stance while the MACD stands at 1.32, meaning price will increase in the next trading period. Percent R indicator moved to 22.26%, implying bullish price movement. Stochastic %K at 84.43% suggest selling the stock.

What is the short interest in ESSA Pharma Inc.?

Short interest in the ESSA Pharma Inc. stock has plunged, decreasing by 3630.0 shares to total 15160.0 shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 11530.0, data from Yahoo Finance shows. The increase of 23.94% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 0.06% of the overall float for the stock.

ESSA Pharma Inc.’s Biggest Shareholders: Who Owns ESSA Pharma Inc. [EPIX]?

Filings by Soleus Capital Management LP showed that the firm now holds a total of 2,844,187 shares or roughly 9.81% of the outstanding EPIX shares. This means their shares have reduced by -528,867 from the 2,844,187 the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, BVF Partners LP updated stake is worth $21,039,123. The OrbiMed Advisors LLC’s holdings currently number 1,177,483 shares at $14153345.66. According to the firm’s last 13F report, Sio Capital Management LLC shares in the company at filing stood at 656,043 shares, roughly $4,592,301.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Torchlight Energy Resources Inc. (TRCH) stock surged during current market trading. Here’s to know why?

Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock gained by 41.33% in the current market trading session. Torchlight Energy Resources is a vast growing oil...

The9 Ltd. (NCTY) stock declined during pre-market trading. Here’s the update

The9 Ltd. (NASDAQ: NCTY) stock plunged by 12% at the last close while the NCTY stock price fell by 7.03% during pre-market trading. The9...

The Dixie Group Inc. (DXYN) stock surged during pre-market trading given no recent news

The Dixie Group Inc. (NASDAQ: DXYN) stock gained by 11.55% in the pre-market trading session. However, there is no update available regarding this hike...

Why BancorpSouth Bank (BXS) stock plummeted on Friday?

BancorpSouth Bank (BXS) shares plummeted 9.39% in after-hours on Friday, June 18, 2021, and close the weekly business at $25.00 per share. Earlier, BXS's...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Anavex Inc. (AVXL) stock soars during pre-market trading. Let’s see why?

Anavex Inc. (AVXL) stock gained by 4.29% at the last close while the AVXL stock price surged by 12.38% in the pre-market trading session....

The9 Ltd. (NCTY) stock declined during pre-market trading. Here’s the update

The9 Ltd. (NASDAQ: NCTY) stock plunged by 12% at the last close while the NCTY stock price fell by 7.03% during pre-market trading. The9...

The Dixie Group Inc. (DXYN) stock surged during pre-market trading given no recent news

The Dixie Group Inc. (NASDAQ: DXYN) stock gained by 11.55% in the pre-market trading session. However, there is no update available regarding this hike...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam